<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04076397</url>
  </required_header>
  <id_info>
    <org_study_id>29BRC19.0081</org_study_id>
    <nct_id>NCT04076397</nct_id>
  </id_info>
  <brief_title>Lipofilling Versus Conservative Treatment in Fingertips Injuries Sequelae</brief_title>
  <acronym>LIPOFILLING</acronym>
  <official_title>Randomized Prospective Study Evaluating the Benefit of the Treatment of the Distal Amputation Sequelae of the Fingers by Lipofilling - LIPOFILLING Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the contribution of autologous graft reinjection&#xD;
      (lipofilling) in the treatment of dysaesthesic pulp.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2020</start_date>
  <completion_date type="Anticipated">April 2, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The randomization list is established by the Brest CHRU data management unit before the start of the trial. Based on a ratio (1: 1) with stratification on the center, the type of initial surgery (directed or flap scarring) and the duration of change of dysesthesia (≤ or&gt; 1 year at baseline).</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of the EVA between D0 and M6</measure>
    <time_frame>Day 0, Month 6</time_frame>
    <description>visual analogue scale from 0 to 10, knowing that 0 is the absence of discomfort and intolerable discomfort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective self-assessment of the overall functional ability of both upper limbs</measure>
    <time_frame>Day 0, Day 15, Month1, Month3, Month6</time_frame>
    <description>DASH questionnaire (Disability of Arm-Shoulder-Hand)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neuropathic pain</measure>
    <time_frame>Day 0, Day 15, Month 1, Month 3, Month 6</time_frame>
    <description>DN4 score (questionnaire) : a score greater than or equal to 4 makes the diagnosis of neuropathic pain.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction on the esthetic aspect of the finger</measure>
    <time_frame>Month 6</time_frame>
    <description>Subjective satisfaction to the patient's appreciation.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Distal Amputation of the Fingers</condition>
  <arm_group>
    <arm_group_label>lipofilling group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient will conduct a total of 4 visits: D15, M1, M3, M6 during which they will have: a clinical examination as well as the following evaluations:&#xD;
Make EVA (evaluation of the pain),&#xD;
Complete DASH questionnaire&#xD;
Complete DN4 questionnaire&#xD;
Patients in the lipofilling group will also have:&#xD;
the repair of the last dressing during the consultation at J15&#xD;
Ablation of any threads&#xD;
Control of the digital and abdominal scar&#xD;
Making a photo of their finger at V1 and M6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>desensitization group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient will conduct a total of 4 visits: D15, M1, M3, M6 during which they will have: a clinical examination as well as the following evaluations:&#xD;
Make EVA (evaluation of the pain),&#xD;
Complete DASH questionnaire&#xD;
Complete DN4 questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous transplant reinjection</intervention_name>
    <description>The patient is placed under loco-regional anesthesia. After sterilization of the upper limb and abdomen, the fat is removed at a fold by micro-incision by the Coleman method. The fat is decanted and micro-reinjected into the pulp of the patient's finger with 2 or 3 punctiform incisions. The quantity of fat injected is 2 to 3 mL. Incision of the abdomen and fingers is closed by points at monocryl 4/0. Finally, a fatty dressing is performed on the finger. Patients will benefit from nursing care every 2 days</description>
    <arm_group_label>lipofilling group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>desensitization</intervention_name>
    <description>Patients will have to stimulate the pulp of your finger on a daily basis</description>
    <arm_group_label>desensitization group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Major patient (18 years old) and ≤ 75 years old&#xD;
&#xD;
          -  Patient with unidigital trauma downstream of distal interphalangeal joint&#xD;
&#xD;
          -  Treated by directed healing OR covered by a flap&#xD;
&#xD;
          -  Presenting troublesome pulpal dysesthesia evolving for more than 6 months AND less&#xD;
             than 24 months&#xD;
&#xD;
          -  The discomfort must be objectified by a DN4 score greater than or equal to 4/10&#xD;
             (neuropathic pain)&#xD;
&#xD;
          -  Patient does not have any allergy to the substances used, in particular anesthetic:&#xD;
             xylocaine, adrenaline&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with cutaneous sepsis, or amputation upstream of distal interphalangeal, or&#xD;
             reimplantation, or dysesthesia that has been in progress for more than 24 months, or&#xD;
             multi-digital traumatism&#xD;
&#xD;
          -  Refusal of the patient to integrate the protocol Or incapacity to consent&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Tumor history of the amputated finger&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nathalie KERFANT, Dr</last_name>
    <phone>02.08.34.25.11</phone>
    <email>nathalie.kerfant@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie KERFANT, Dr</last_name>
      <phone>02.08.34.25.11</phone>
      <email>nathalie.kerfant@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie KERFANT, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hoel LETISSIER, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Charlotte MONNERIE, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra TRIMAILLE, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Cornouaille - Quimper</name>
      <address>
        <city>Quimper</city>
        <zip>29107</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Charlotte MONNERIE, Dr</last_name>
      <email>anne-charlotte.monnerie@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Charlotte MONNERIE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2019</study_first_posted>
  <last_update_submitted>June 1, 2021</last_update_submitted>
  <last_update_submitted_qc>June 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>annoying pulpal dysesthesia</keyword>
  <keyword>lipofilling</keyword>
  <keyword>amputation</keyword>
  <keyword>sequelae</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning three years and ending fifteen years following the final study report completion</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

